Evaluation Of The Use Of Antidiabetic Drugs For Geriatric Patients With Type 2 Diabetes Mellitus In Outpatient Care At Fatmawati Hospital, South Jakarta In 2023
##plugins.themes.academic_pro.article.sidebar##
##plugins.themes.academic_pro.article.main##
Abstract
Diabetes mellitus is a non-communicable disease that has a large prevalence and is increasing every year in Indonesia. Evaluation of the use of antidiabetic drugs aims to ensure that patients with diabetes mellitus use antidiabetic drugs appropriately. This study is an observational study with retrospective descriptive analysis using patient medical record data. In this study, an evaluation was carried out on outpatient type 2 diabetes mellitus geriatric patients with a total of 200 patients based on PERKENI in 2021 with an accuracy standard of 100%. Evaluation of drug use is divided into 3 parameters, namely the right indication, the right drug, and the right dose. Based on the analysis of demographic data, most patients are at the age of 60-69 years and are female. Based on clinical data analysis, patients with the highest level of diabetes are type 2 diabetes mellitus without comorbidities or complications. Based on the results of the evaluation, the most common pattern of drug use is monotherapy. Based on the evaluation results, the right indication was obtained for 200 patients (100%), the right drug for 178 patients (89%) and the right dose for 199 patients (99.5%). Based on Hemoglobin A1c, FBS, PGB and RBGS, 188 patients (94%) had controlled diabetes. In this study, it can be concluded that there are still discrepancies in the use of antidiabetic drugs in outpatient type 2 diabetes mellitus geriatric patients at Fatmawati General Hospital in 2023.
##plugins.themes.academic_pro.article.details##
References
2. International Diabetes Federation. IDF Diabetes Atlas 2021 _ IDF Diabetes Atlas [Internet]. IDF official website. 2021 [dikutip 29 Mei 2024]. Tersedia pada: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf
3. Munira SL, Tim Penyusun Badan Kebijakan Pembangunan Kesehatan. Survei Kesehatan Indonesia (SKI). Jakarta; 2023
4. Dinas Kesehatan Provinsi DKI Jakarta. Profil Kesehatan Provinsi DKI Jakarta Tahun 2020. Vol. 1, Dinas Kesehatan Provinsi DKI Jakarta. 2020.
5. Profil Kesehatan Dki Jakarta 2021 Dan Lampiran. Dinas Kesehatan Provinsi DKI Jakarta. 2021;
6. Kurniawan I. Diabetes Melitus Tipe 2 pada Usia Lanjut Type 2 Diabetes Melitus in The Elderly. Tinjauan Pustaka Maj Kedokt Indon. 2010;
7. ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L, dkk. 13. Older Adults: Standards of Care in Diabetes—2024. Diabetes Care. 1 Januari 2024;47(Supplement_1):S244–57.
8. Milita F, Handayani S, Setiaji B. Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018). Jurnal Kedokteran dan Kesehatan. 2021;17(1).
9. Almasdy D, Sari DP, Suhatri S, Darwin D, Kurniasih N. Evaluasi Penggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe-2 di Suatu Rumah Sakit Pemerintah Kota Padang – Sumatera Barat. Jurnal Sains Farmasi & Klinis. 2015;2(1).
10. Wulandari A, Luthfiyanti N, S.A K. Evaluasi Ketepatan Pemilihan Obat dan Outcome Terapi pada Pasien Diabetes Melitus Tipe II Rawat Jalan di RSUD Dr. Moewardi Surakarta. Agustus 2023;8.
11. Kurniawati T, Lestari D, Rahayu AP, Syaputri FN, Tugon DTA. Evaluasi Profil Penggunaan Obat Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan di Salah Satu Rumah Sakit Kabupaten Bogor. Jste. 2021;3(1).
12. Soelistijo S. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021 [Internet]. Global Initiative for Asthma. 2021 [dikutip 31 Mei 2024]. Tersedia pada: https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf
13. Sengaji M, Herlina S, Wibisono N. Hubungan Polifarmasi Dengan Potensi Dan Tingkat Keparahan Interaksi Obat Pada Resep Antidiabetes Mellitus.
14. Mulyani Y, Siti Balqis S, Sutrisno E, Anggriani A. Mulyani: Analisis Hubungan Polifarmasi Dengan Potensi Interaksi Obat Pada Peresepan Pasien Diabetes Melitus Tipe 2 Analisis Hubungan Polifarmasi Dengan Potensi Interaksi Obat Pada Peresepan Pasien Diabetes Melitus Tipe 2 Analysis of the Relationship Between Polypharmacy and the Potential for Drug Interactions in the Prescription of Patients with Type 2 Diabetes Mellitus. Jurnal Farmasi Galenika. 11(2).